Phase II trial of GDC-0980 (dual PI3K/mTOR inhibitor) in patients with advanced endometrial carcinoma: Final study results Meeting Abstract
| Authors: | Makker, V.; Recio, F. O.; Ma, L.; Matutonis, U.; Lauchle, J. O.; Parmar, H.; Gilbert, H.; Wang, Y. L.; Koeppen, H.; Spoerke, J. M.; Lackner, M.; Aghajanian, C. |
| Abstract Title: | Phase II trial of GDC-0980 (dual PI3K/mTOR inhibitor) in patients with advanced endometrial carcinoma: Final study results |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613203498 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.5513 |
| Notes: | Meeting Abstract: 5513 -- Source: Wos |
